title: Compliance and fixed-dose combination therapy in a sample of greek hypertensive patients.
authors.forename: Athanasia K
authors.initials: AK
authors.lastname: Papazafiropoulou
authors.forename: Alexios
authors.initials: A
authors.lastname: Sotiropoulos
authors.forename: Kyriakos
authors.initials: K
authors.lastname: Souliotis
authors.forename: George
authors.initials: G
authors.lastname: Parcharidis
authors.forename: George
authors.initials: G
authors.lastname: Deligiannis
authors.forename: George
authors.initials: G
authors.lastname: Gionakis
authors.forename: Stefanos
authors.initials: S
authors.lastname: Papoulis
authors.forename: Eystathios
authors.initials: E
authors.lastname: Skliros
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006115:Greece; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance / Q000706:statistics & numerical data*; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics; D004338:Drug Combinations